Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
Biochemical and Biophysical Research Communications|October 22, 2008
Geranylgeranyl transferase type II inhibition prevents myeloma bone diseaseMichelle A Lawson, Les Coulton, Frank H Ebetino, et al.
Nature Communications|May 13, 2017
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cellsRodrigo Vazquez-Lombardi, Claudia Loetsch, Daniela Zinkl, et al.
The Journal of Endocrinology|August 19, 2016
Rapid phenotyping of knockout mice to identify genetic determinants of bone strengthBernard Freudenthal, John Logan, , et al.
Frontiers in Immunology|June 17, 2021
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV InfectionGerald Mak, John J Zaunders, Michelle Bailey, et al.
Nature Communications|December 4, 2015
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal nicheMichelle A Lawson, Michelle M McDonald, Natasa Kovacic, et al.
Cancer Research|January 11, 2007
An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myelomaDeborah J Heath, Karin Vanderkerken, Xin Cheng, et al.
Current Protocols in Mouse Biology|June 13, 2015
Bone Mineral Content and DensityChristopher T Esapa, J H Duncan Bassett, Holly Evans, et al.
Frontiers in Immunology|December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsChansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Pageof 17